Baupost Group - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 34 filers reported holding FINCH THERAPEUTICS GROUP INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Baupost Group ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$793
+62.2%
2,019,008
+98.1%
0.01%
+75.0%
Q4 2022$489
-100.0%
1,019,008
-9.3%
0.01%
-75.0%
Q3 2022$1,876,000
-41.2%
1,123,1080.0%0.03%
-31.9%
Q2 2022$3,190,000
-43.5%
1,123,1080.0%0.05%
-23.0%
Q1 2022$5,649,000
-50.0%
1,123,108
-0.8%
0.06%
-45.0%
Q4 2021$11,289,000
-28.1%
1,132,253
-6.3%
0.11%
-22.9%
Q3 2021$15,706,000
-5.9%
1,208,1590.0%0.14%
+6.7%
Q2 2021$16,693,000
-11.5%
1,208,1590.0%0.14%
-10.0%
Q1 2021$18,870,0001,208,1590.15%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q1 2023
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$653,7033.23%
Bleichroeder LP 810,416$318,4930.07%
Ikarian Capital, LLC 237,553$93,3590.02%
LAKE STREET ADVISORS GROUP, LLC 739,136$2910.02%
Baupost Group 2,019,008$7930.01%
Proficio Capital Partners LLC 110,559$43,4500.01%
MSD Partners, L.P. 153,397$60,2850.01%
Ballentine Partners, LLC 143,603$56,4360.00%
SVB WEALTH LLC 253,054$99,4500.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 18,783$7,3820.00%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders